HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of triple therapy versus dual therapy for lymphatic filariasis: A systematic review and meta-analysis.

AbstractOBJECTIVE:
Lymphatic filariasis is a serious public health issue. Recent studies showed that a single dosage of triple therapy (Ivermectin, Diethylcarbamazepine, and Albendazole) is more effective than dual therapy (Ivermectin plus Albendazole or Diethylcarbamazepine plus Albendazole) for clearing microfilaria from the blood. We aimed to evaluate the efficacy and safety of triple therapy versus dual therapy in patients infected with microfilaria and communities endemic to lymphatic filariasis.
METHODS:
For this systematic review and meta-analysis, we searched MEDLINE, EMBASE, SCOPUS, Cochrane Central Register of Controlled Trials, and Web of Science until 24th June 2021. We included randomized control trials that compared triple with dual therapy given to patients with lymphatic filariasis or endemic communities. This study was registered with PROSPERO (CRD42021266724).
RESULTS:
We included eight articles after the screening process. Triple therapy caused more clearance of microfilaria in the blood (RR: 1.52; 95% CI: 1.15, 2.02; p = 0.003), while dual therapy caused more clearance of the circulating filariae antigen in the blood (RR: 0.76; 95% CI: 0.65, 0.88; p = 0.0003), both 12 months after drug administration. The triple therapy had a similar adverse effect compared with the dual therapy group.
CONCLUSION:
Based on the greater efficacy in the clearance of microfilaria and the safety of triple therapy, it constitutes a better strategy for the eradication programs of lymphatic filariasis in endemic regions. However, further studies are needed to confirm our results.
AuthorsMohamed T Abuelazm, Basel Abdelazeem, Helmy Badr, Mohamed Gamal, Mohamed Ashraf, Sherief Abd-Elsalam
JournalTropical medicine & international health : TM & IH (Trop Med Int Health) Vol. 27 Issue 3 Pg. 226-235 (03 2022) ISSN: 1365-3156 [Electronic] England
PMID35080325 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
Copyright© 2022 John Wiley & Sons Ltd.
Chemical References
  • Filaricides
  • Ivermectin
  • Albendazole
  • Diethylcarbamazine
Topics
  • Albendazole (adverse effects)
  • Animals
  • Diethylcarbamazine (adverse effects)
  • Drug Therapy, Combination
  • Elephantiasis, Filarial (drug therapy)
  • Filaricides (adverse effects)
  • Humans
  • Ivermectin (therapeutic use)
  • Microfilariae

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: